JG
RIGL icon

Jefferies Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Jefferies Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,712
Closed -$32K – 2913
2019
Q3 		$32K Buy
+1,712
New +$35.4K ﹤0.01% 2607
2019
Q1 		– Sell
-4,850
Closed -$112K – 2574
2018
Q4 		$112K Sell
4,850
-2,890
-37% -$81.6K ﹤0.01% 1950
2018
Q3 		$248K Buy
7,740
+3,420
+79% +$103K ﹤0.01% 1973
2018
Q2 		$122K Buy
+4,320
New +$154K ﹤0.01% 2108
2015
Q2 		– Sell
-100
Closed -$4K – 3466
2015
Q1 		$4K Buy
+100
New +$2.74K ﹤0.01% 2013

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jefferies Group's RIGL Position: Q4 2019 in Review

Jefferies Group sold out of Rigel Pharmaceuticals (RIGL) in Q4 2019, closing a stake of 1,712 shares — an estimated $32K sold.

Jefferies Group first reported a position in RIGL in Q1 2015 and held it in 5 quarters. The position peaked at $248K in Q3 2018. 136 funds tracked by Wall St. Rank hold RIGL as of Q4 2019.

  • Jefferies Group reported no remaining Rigel Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Jefferies Group sold 1,712 Rigel Pharmaceuticals shares in Q4 2019, an estimated $32K.
  • Jefferies Group first reported a position in Rigel Pharmaceuticals in Q1 2015 and held it in 5 quarters.
  • Jefferies Group's Rigel Pharmaceuticals position peaked at $248K in Q3 2018.
  • 136 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.